| Product NDC: | 0075-2451 |
| Proprietary Name: | DDAVP |
| Non Proprietary Name: | desmopressin acetate |
| Active Ingredient(s): | 4 ug/mL & nbsp; desmopressin acetate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0075-2451 |
| Labeler Name: | sanofi-aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018938 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19840330 |
| Package NDC: | 0075-2451-53 |
| Package Description: | 1 VIAL, MULTI-DOSE in 1 CARTON (0075-2451-53) > 10 mL in 1 VIAL, MULTI-DOSE |
| NDC Code | 0075-2451-53 |
| Proprietary Name | DDAVP |
| Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (0075-2451-53) > 10 mL in 1 VIAL, MULTI-DOSE |
| Product NDC | 0075-2451 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | desmopressin acetate |
| Dosage Form Name | SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19840330 |
| Marketing Category Name | NDA |
| Labeler Name | sanofi-aventis U.S. LLC |
| Substance Name | DESMOPRESSIN ACETATE |
| Strength Number | 4 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | Factor VIII Activator [EPC],Increased Coagulation Factor VIII Activity [PE],Increased Coagulation Factor VIII Concentration [PE],Vasopressin Analog [EPC],Vasopressins [Chemical/Ingredient] |